Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1918 1
1942 1
1945 1
1946 4
1947 1
1948 1
1949 3
1952 3
1954 2
1955 2
1956 1
1957 1
1958 5
1959 4
1960 3
1961 5
1962 7
1963 9
1964 9
1965 5
1966 10
1967 3
1968 10
1969 12
1970 18
1971 15
1972 13
1973 9
1974 11
1975 15
1976 23
1977 19
1978 20
1979 19
1980 21
1981 29
1982 32
1983 14
1984 30
1985 20
1986 32
1987 52
1988 53
1989 46
1990 77
1991 90
1992 102
1993 95
1994 142
1995 157
1996 179
1997 221
1998 265
1999 328
2000 446
2001 548
2002 647
2003 739
2004 944
2005 1103
2006 1282
2007 1566
2008 1872
2009 2082
2010 2559
2011 3017
2012 3383
2013 3619
2014 3895
2015 4256
2016 4368
2017 4404
2018 4599
2019 4897
2020 5450
2021 5911
2022 5555
2023 5455
2024 5535
2025 5664
2026 99

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76,740 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Among authors: park jo. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Free article. Clinical Trial.
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial.
Kim D, Shim J, Choi EK, Oh IY, Kim J, Lee YS, Park J, Ko JS, Park KM, Sung JH, Park HW, Park HS, Kim JY, Kang KW, Kim D, Park JK, Kim DH, Kim JB, Yu HT, Kim TH, Uhm JS, Pak HN, Joung B; ALONE-AF Investigators. Kim D, et al. Among authors: park jk, park j. JAMA. 2025 Oct 14;334(14):1246-1254. doi: 10.1001/jama.2025.14679. JAMA. 2025. PMID: 40886309 Clinical Trial.
Vitamin D Supplementation and Prevention of Type 2 Diabetes.
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M; D2d Research Group. Pittas AG, et al. Among authors: park j. N Engl J Med. 2019 Aug 8;381(6):520-530. doi: 10.1056/NEJMoa1900906. Epub 2019 Jun 7. N Engl J Med. 2019. PMID: 31173679 Free PMC article. Clinical Trial.
Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.
Schram AM, Goto K, Kim DW, Macarulla T, Hollebecque A, O'Reilly EM, Ou SI, Rodon J, Rha SY, Nishino K, Duruisseaux M, Park JO, Neuzillet C, Liu SV, Weinberg BA, Cleary JM, Calvo E, Umemoto K, Nagasaka M, Springfeld C, Bekaii-Saab T, O'Kane GM, Opdam F, Reiss KA, Joe AK, Wasserman E, Stalbovskaya V, Ford J, Adeyemi S, Jain L, Jauhari S, Drilon A; eNRGy Investigators. Schram AM, et al. Among authors: park jo. N Engl J Med. 2025 Feb 6;392(6):566-576. doi: 10.1056/NEJMoa2405008. N Engl J Med. 2025. PMID: 39908431 Free PMC article. Clinical Trial.
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
Li BT, Meric-Bernstam F, Bardia A, Naito Y, Siena S, Aftimos P, Anderson I, Curigliano G, de Miguel M, Kalra M, Oh DY, Park JO, Postel-Vinay S, Rha SY, Satoh T, Spanggaard I, Michelini F, Smith A, Machado KK, Saura C; DESTINY-PanTumor01 study group. Li BT, et al. Among authors: park jo. Lancet Oncol. 2024 Jun;25(6):707-719. doi: 10.1016/S1470-2045(24)00140-2. Epub 2024 May 3. Lancet Oncol. 2024. PMID: 38710187 Clinical Trial.
Whole-genome landscapes of 1,364 breast cancers.
Kim R, Yu J, Lim J, Oh BB, Nam SJ, Kim SW, Lee JE, Chae BJ, Kim JY, Park GE, Kang BJ, Paik PS, Bae SY, Yoon CI, Lee YJ, Kim D, Shin K, Lee JE, Kang J, Lee A, Connolly-Strong E, Lee S, Lee BR, Lee Y, Yi KJ, Kwon YO, Chun IH, Park J, Kim J, Choi C, Shin JY, Lee H, Kim M, Park H, Jeong I, Yi B, Lee WC, Lee JS, Park WC, Kim SH, Choi YL, Lee J, Ju YS, Park YH. Kim R, et al. Among authors: park j. Nature. 2025 Dec 3. doi: 10.1038/s41586-025-09812-3. Online ahead of print. Nature. 2025. PMID: 41339552
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery.
Kang DY, Lee SH, Lee SW, Lee CH, Kim C, Jang JY, Mehta N, Oh JH, Cho YR, Yoon KH, Ahn SG, Lee JH, Cho DK, Kim Y, Kim J, Cho GH, Lee KS, Park H, Vural M, Lim YH, Park KH, Lee BK, Lee JY, Park HW, Yoon YH, Lee JH, Lee SY, Park KW, Kang J, Kim HK, Kang SH, Park JH, Choi IC, Yu CS, Yun SC, Park DW, Hong MK, Park SJ, Kim JS, Ahn JM; ASSURE DES Investigators. Kang DY, et al. Among authors: park jh. J Am Coll Cardiol. 2024 Dec 10;84(24):2380-2389. doi: 10.1016/j.jacc.2024.08.024. Epub 2024 Aug 31. J Am Coll Cardiol. 2024. PMID: 39217573 Free article. Clinical Trial.
Developing Topics.
Park J, He Z, Greicius MD. Park J, et al. Alzheimers Dement. 2025 Dec;21 Suppl 7(Suppl 7):e108637. doi: 10.1002/alz70861_108637. Alzheimers Dement. 2025. PMID: 41434507 Free PMC article.
Public Health.
Hong YJ, Lee SB, Kim SH, Park JW, Kim M. Hong YJ, et al. Among authors: park jw. Alzheimers Dement. 2025 Dec;21 Suppl 6(Suppl 6):e102460. doi: 10.1002/alz70860_102460. Alzheimers Dement. 2025. PMID: 41435268 Free PMC article.
76,740 results
You have reached the last available page of results. Please see the User Guide for more information.